Dr Mike Egan

Dr. Mike Egan is a Senior Business Development Manager at the Infection Innovation Consortium, where he leads the development of the new £10m CL3 high-containment organoid laboratories in partnership with the Liverpool School of Tropical Medicine. These cutting-edge labs will combine robotics and artificial intelligence to speed up the discovery and development of life-saving treatments for infectious diseases.

As a Chartered Engineer and Chartered Manager, he brings nearly 20 years of experience working at the crossroads of academia and industry. Mike’s background covers a broad range of areas including robotics, machine design, manufacturing, formulation, processing, scale-up, and project management.

He earned his PhD in Manufacturing Engineering and Industrial Management, focusing on developing innovative equipment for rapid pharmaceutical dosage manufacturing using inkjet printing. After that, Mike spent eight years managing the Ultra Mixing and Processing Facility in the Department of Chemistry. During that time, he collaborated closely with Unilever and TecExec Ltd, developing new fluid processing technologies. This work led to several patents, a joint venture, the creation of process scale-up rules, and the installation of pilot plant machinery at two commercial sites.

Mike then spent nine years at the University of Liverpool's Materials Innovation Factory, where he led the development and commercialisation of advanced automation technologies. One of his key projects was the £3m Henry Royce Institute-funded Formulation Engine – a robotic platform that transformed materials chemistry research by automating complex scientific processes.

Mike is passionate about using cutting-edge technology to drive scientific innovation and deliver real-world impact. At the Infection Innovation Consortium, he is excited to continue pushing the boundaries of what's possible and support collaborations that bridge research and practical solutions.